Search

Your search keyword '"Volders P. G. A."' showing total 84 results

Search Constraints

Start Over You searched for: Author "Volders P. G. A." Remove constraint Author: "Volders P. G. A."
84 results on '"Volders P. G. A."'

Search Results

3. Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility

5. Temporal variability of electromechanical-window negativity in patients with inherited long-QT syndrome or drug-induced QT prolongation: relation to torsades de pointes

6. Mitral Annular Disjunction in Idiopathic Ventricular Fibrillation Patients: Just a Bystander or a Potential Cause?

7. Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility

19. Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls

20. Edward Carmeliet (1930-2021) - Channelling scientific curiosity: A tribute from the ESC Working Group on Cardiac Cellular Electrophysiology

21. Mutation location and IKsregulation in the arrhythmic risk of long QT syndrome type 1: The importance of the KCNQ1 S6 region

28. Repolarization instability and arrhythmia by IKr block in single human-induced pluripotent stem cell-derived cardiomyocytes and 2D monolayers

32. The Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status update.

35. Lamin A/C-Related Cardiac Disease: Late Onset With a Variable and Mild Phenotype in a Large Cohort of Patients With the Lamin A/C p.(Arg331Gln) Founder Mutation.

37. Minimum Information about a Cardiac Electrophysiology Experiment (MICEE): Standardised reporting for model reproducibility, interoperability, and data sharing

38. Minimum Information about a Cardiac Electrophysiology Experiment (MICEE):standardised reporting for model reproducibility, interoperability, and data sharing

41. Poster session 3

42. Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy

46. Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members

47. Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Diagnostic Task Force Criteria.

48. Electrocardiographic changes predicting sudden death in propofol-related infusion syndrome.

50. Role of the NaCa Exchanger in Arrhythmias in Compensated Hypertrophy

Catalog

Books, media, physical & digital resources